Related Experiment Videos
Misoprostol-associated platelet aggregation dysfunction and increased gastrointestinal blood loss
I L Beales1, M Clemons, W M Kong
1Department of Gastroenterology, Hammersmith Hospital, London, UK.
European Journal of Gastroenterology & Hepatology
|January 1, 1997
Summary
Misoprostol use can cause acquired platelet dysfunction, leading to prolonged bleeding. This case study shows that stopping misoprostol improved platelet function and reduced gastrointestinal blood loss.
Area of Science:
- Gastroenterology
- Hematology
- Pharmacology
Background:
- Gastrointestinal (GI) bleeding is a significant clinical concern, particularly in elderly patients.
- Widespread telangiectases can cause chronic, difficult-to-manage GI blood loss.
- Platelet dysfunction can exacerbate bleeding episodes.
Observation:
- A 70-year-old male patient presented with chronic GI hemorrhage due to extensive telangiectasias.
- Diagnostic workup revealed a prolonged bleeding time and significantly impaired platelet aggregation.
- The patient was reportedly using misoprostol, a prostaglandin analog.
Findings:
- Discontinuation of misoprostol therapy led to the normalization of bleeding time.
- Platelet aggregation function improved markedly after misoprostol withdrawal.
- The findings suggest a causal link between misoprostol and acquired platelet dysfunction.
Implications:
- Misoprostol should be considered as a potential cause of acquired platelet defects.
- Clinicians should monitor for bleeding complications in patients using misoprostol, especially those with pre-existing bleeding risks.
- Understanding this adverse effect can help prevent or manage gastrointestinal blood loss in susceptible individuals.